Bryan Wolf, M.D., is featured in an opinion column by Nicholas Kristof.

Continued coverage of statewide recruitment efforts for the OHSU-led study to track the spread of the novel coronavirus.

Luiz Bertassoni, D.D.S., Ph.D., leads the design of tiny, Lego-inspired, 3D-printed bricks designed to heal broken bones.

OHSU participates in new initiative with Regence to reduce administrative costs and improve quality.

KGW-TV covers health care workers standing against structural racism in protests downtown. In a statement, OHSU says, “We recognize the important role our students, faculty, residents and staff play as members of the broader community and respect their right as individuals to be involved in lawful civic and community activities.”

In a story about scientists resuming research that was paused during the pandemic, Isabella Rauch, Ph.D., notes about half of the normal number of people are able to be in her lab at a time due to physical distancing.

An article covers new research led by Chafic Karam, M.D., regarding a new treatment for spinal muscular atrophy. He says, “We think there is no dramatic improvement with nusinersen treatment, maybe only modest benefits, and it comes with its own risks that must be explained clearly to the patient.”

Louis Picker, M.D., recalls how Robert Nelsen of ARCH Venture Partners saw value in the OHSU spinoff and vaccine development startup TomegaVax, Inc., which was later acquired by Vir Biotechnology, in a feature about infectious disease technology investment.

Anita Randolph, Ph.D., says, “I’m happy some people are coming out, but not many people have been asking the Black community what they need.”

Mark Lovgren, M.B.A., and Alison Loh, M.D., discuss OHSU’s increased telehealth offerings and Winston Chamberlain, M.D., describes how digital technology use can led to dry eye in a healthcare and technology supplement of The Oregonian.